travatan travoprost eye drops 2.5ml 0.1mg 2

Description

Indication & Scope

TRAVATAN® is a prescription prostaglandin analog ophthalmic solution indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, particularly in those who are intolerant of or insufficiently responsive to other intraocular pressure-lowering medications.

Mechanism: Travoprost is a synthetic prostaglandin F₂α analog that lowers intraocular pressure by increasing aqueous humor outflow primarily through the uveoscleral pathway, with minimal effect on aqueous humor production.
Drug class: Prostaglandin analog (Antiglaucoma agent).
Clinical use: Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, especially in those with an inadequate response or intolerance to other ocular hypotensive therapies.

Specification

Generic Name	Travoprost Ophthalmic Solution
Brand Name	TRAVATAN®
Ingredient	Travoprost
Dosage Form	Eye Drops
Package	2.5 mL: 0.1 mg (0.004%)/bottle
Conditions Treated	Open-angle glaucoma; Ocular hypertension
Taboos	Hypersensitivity to travoprost, prostaglandin analogs, or any component of the product
Place of origin	Spain
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store at 2–25°C, protected from light. Do not freeze. Discard the bottle 4 weeks after opening.
Manufacturer	Siegfried El Masnou, S.A., Spain
Registration Authority	National Medical Products Administration (NMPA), China
Approval number	HJ20181024
Date of Revision	June 09, 2022
Shelf Life	24 months

How to use ?

Recommended Dose: Instill one drop into the affected eye(s) once daily in the evening.

Time: Evening administration provides optimal intraocular pressure reduction. Do not exceed one dose per day, as more frequent administration may reduce the intraocular pressure-lowering effect.

Instructions for use: For ophthalmic use only. If a dose is missed, continue with the next scheduled dose without applying an additional drop. After administration, gently press the inner corner of the eye near the tear duct for approximately 2 minutes to reduce systemic absorption. When using other ophthalmic medications, allow an interval of at least 5 minutes between applications. TRAVATAN® is preserved with POLYQUAD® instead of benzalkonium chloride, and contact lenses generally do not need to be removed before instillation unless otherwise directed by a healthcare professional.

Interaction: No clinically significant systemic drug interactions have been identified. Concomitant use with two or more prostaglandin analogs is not recommended, as it may reduce the intraocular pressure-lowering effect or produce paradoxical responses.

Side effects: Common adverse reactions include conjunctival hyperemia, eye discomfort, foreign body sensation, eye pain, ocular pruritus, dry eye, iris pigmentation changes, eyelid pigmentation, eyelash growth, blurred vision, superficial punctate keratitis, blepharitis, photophobia, increased lacrimation, eyelid edema, headache, dizziness, and rare hypersensitivity reactions.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is TRAVATAN® (Travoprost) used for?

TRAVATAN® is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, especially in those who are intolerant of or have an inadequate response to other intraocular pressure-lowering medications.

How often should TRAVATAN® (Travoprost) be used?

The recommended dosage is one drop into the affected eye(s) once daily in the evening. More frequent administration is not recommended because it may reduce the therapeutic effect.

Can TRAVATAN® (Travoprost) permanently change eye color?

Yes. Long-term treatment may cause permanent darkening of the iris and increased pigmentation of the eyelids. Eyelashes may also become longer, thicker, and darker.

What are the most common side effects of TRAVATAN® (Travoprost)?

The most common side effects include conjunctival redness, eye irritation, dry eye, foreign body sensation, iris pigmentation changes, eyelash growth, blurred vision, and eyelid pigmentation.